Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Want to see HK:2509 full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting Qyuns Therapeutics Co., Ltd. Class H is a Sell.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 20-Day exponential moving average is 16.59, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$28.58, making it a Sell.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 50-Day exponential moving average is 17.58, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$28.58, making it a Sell.
Qyuns Therapeutics Co., Ltd. Class H (2509) Pivot Points
Classic
13.81
14.50
14.91
15.60
16.01
16.70
17.11
Fibonacci
14.50
14.92
15.18
15.60
16.02
16.28
16.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Qyuns Therapeutics Co., Ltd. Class H (2509) Moving Averages
MA5
16.14Sell
15.92Sell
MA10
16.09Sell
16.15Sell
MA20
16.58Sell
16.59Sell
MA50
18.01Sell
17.58Sell
MA100
19.00Sell
18.56Sell
MA200
21.69Sell
20.11Sell
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 10-Day exponential moving average is 16.15, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$28.58, making it a Sell.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) 100-Day exponential moving average is 18.56, while Qyuns Therapeutics Co., Ltd. Class H’s (2509) share price is HK$28.58, making it a Sell.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$28.58 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 50-day simple moving average is 18.01, creating a Sell signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$28.58 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 100-day simple moving average is 19.00, creating a Sell signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) stock price is HK$28.58 and Qyuns Therapeutics Co., Ltd. Class H’s (2509) 200-day simple moving average is 21.69, creating a Sell signal.
Qyuns Therapeutics Co., Ltd. Class H (2509) Technical Indicators
RSI (14)
38.46
Neutral
STOCH (9,6)
42.60
Neutral
STOCHRSI (14)
31.09
Neutral
MACD (12,26)
-0.59
Sell
ADX (14)
15.08
Buy
Williams %R
-72.63
Buy
CCI (14)
-108.79
Buy
ATR (14)
1.05
-
Ultimate Oscillator
48.15
Neutral
ROC
-9.19
Sell
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Relative Strength Index (RSI) is 38.46, creating a Neutral signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Trend Strength Indicator (ADX) is 15.08, creating a Buy signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Commodity Channel Index (CCI) is -108.79, creating a Buy signal.
Qyuns Therapeutics Co., Ltd. Class H’s (2509) Price Rate of Change (ROC) is -9.19, creating a Sell signal.
FAQ
Is 2509 a Buy, Hold, or Sell?
Based on 2509’s technical indicators, 2509 is a Strong Sell.
What is 2509’s RSI (14)?
2509’s RSI (14) is 38.46, which suggests 2509 is a Neutral.
What is 2509’s MACD?
2509’s MACD is -0.59, which suggests 2509 is a Sell.
What is 2509’s 5-day moving average?
2509’s 5-day moving average is 16.14, which suggests 2509 is a Sell.
What is 2509’s 20-day moving average?
2509 20-day moving average is 16.58, which suggests 2509 is a Sell.
What is 2509’s 50-day moving average?
2509’s 50-day moving average is 18.01, which suggests 2509 is a Sell.
What is 2509’s 200-day moving average?
2509’s 200-day moving average is 21.69, which suggests 2509 is a Sell.
What is 2509’s Williams % R (14)?
2509’s Williams % R (14) is -72.63, which suggests 2509 is a Buy.
What is 2509’s CCI (14)?
2509’s CCI (14) is -108.79, which suggests 2509 is a Buy.
What is the share price of Qyuns Therapeutics Co., Ltd. Class H?